FCP
CME icon

Fidelis Capital Partners’s CME Group CME Stock Holding History

Fidelis Capital Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
1,643
-51
-3% -$14.1K 0.02% 397
2026
Q1 		$500K Buy
1,694
+101
+6% +$30K 0.04% 319
2025
Q4 		$435K Buy
1,593
+224
+16% +$60.9K 0.03% 338
2025
Q3 		$370K Buy
1,369
+108
+9% +$29.4K 0.03% 355
2025
Q2 		$355K Buy
1,261
+57
+5% +$15.5K 0.03% 319
2025
Q1 		$321K Buy
1,204
+111
+10% +$27.4K 0.03% 310
2024
Q4 		$263K Buy
1,093
+126
+13% +$29K 0.03% 361
2024
Q3 		$220K Buy
+967
New +$200K 0.03% 376
2024
Q2 		– Sell
-936
Closed -$202K – 382
2024
Q1 		$202K Sell
936
-739
-44% -$155K 0.03% 355
2023
Q4 		$353K Buy
1,675
+275
+20% +$58.7K 0.08% 220
2023
Q3 		$280K Buy
1,400
+52
+4% +$10.3K 0.1% 203
2023
Q2 		$250K Buy
1,348
+176
+15% +$32.5K 0.09% 229
2023
Q1 		$217K Buy
+1,172
New +$212K 0.09% 224

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fidelis Capital Partners's CME Position: Q2 2026 in Review

Fidelis Capital Partners reduced its CME Group (CME) stake by 3% in Q2 2026, selling an estimated $14.1K and leaving 1,643 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #397.

Fidelis Capital Partners first reported a position in CME in Q1 2023 and has held it in 13 quarters since. The position peaked at $500K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Fidelis Capital Partners held 1,643 shares of CME Group worth $363K as of Q2 2026.
  • Fidelis Capital Partners sold 51 CME Group shares in Q2 2026, an estimated $14.1K.
  • CME Group made up 0.02% of Fidelis Capital Partners's portfolio in Q2 2026, its #397 holding.
  • Fidelis Capital Partners first reported a position in CME Group in Q1 2023 and has held it in 13 quarters since.
  • Fidelis Capital Partners's CME Group position peaked at $500K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.